rispolept 2 mg tabletki powlekane
janssen-cilag international n.v. - risperidonum - tabletki powlekane - 2 mg
rispolept 3 mg tabletki powlekane
janssen-cilag international n.v. - risperidonum - tabletki powlekane - 3 mg
rispolept 4 mg tabletki powlekane
janssen-cilag international n.v. - risperidonum - tabletki powlekane - 4 mg
durogesic 25 mcg/h system transdermalny
janssen-cilag international n.v. - fentanylum - system transdermalny - 25 mcg/h
durogesic 50 mcg/h system transdermalny
janssen-cilag international n.v. - fentanylum - system transdermalny - 50 mcg/h
durogesic 75 mcg/h system transdermalny
janssen-cilag international n.v. - fentanylum - system transdermalny - 75 mcg/h
durogesic 100 mcg/h system transdermalny
janssen-cilag international n.v. - fentanylum - system transdermalny - 100 mcg/h
rispolept 1 mg/ml roztwór doustny
janssen-cilag international n.v. - risperidonum - roztwór doustny - 1 mg/ml
durogesic 12 mcg/h system transdermalny
janssen-cilag international n.v. - fentanylum - system transdermalny - 12 mcg/h
ponvory
janssen-cilag international n.v. - ponesimod - stwardnienie rozsiane, Рецидивно-znika - leki immunosupresyjne - ponvory is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.